MedTrace Logo

E-Nose: Diagnostic Tool for Pleural TB

NCT02765087 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-11-14

No results posted yet for this study

Summary

The purpose of this study is to determine the diagnostic utility of the device 'Electronic Nose' for Pleural TB, which is a Extra pulmonary TB form, compared with pleural biopsy, the current gold standard.

Conditions

  • Tuberculosis, Pleural

Interventions

OTHER

Medical History

Oriented Survey and complete physical exam.

DEVICE

E-Nose

Patient will breath trough the device for 5 minutes, and during and after the intervention will be assessed for adverse effects related to the use of the e-Nose, according to the CTCEA

OTHER

Chest CT

OTHER

Pleural Fluid Analysis

Cytomorphology Cytochemistry Adenosine Deaminase Value

Sponsors & Collaborators

  • The ENose Company, Zutphen, Netherlands

    collaborator UNKNOWN

  • Foundation for Research in Mycobacteria (FUNDAIM)

    collaborator OTHER

  • Universidad Central de Venezuela

    lead OTHER

Principal Investigators

  • Jacobuss de Waard, PhD. · Instituto de Biomedicina

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Venezuela

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02765087 on ClinicalTrials.gov